Podcasts about Liver transplantation

Could the very supplements you trust to keep you healthy be quietly destroying your liver?Did you know? Most Americans take daily multivitamins or pop turmeric capsules, believing they're making smart choices. With depleted soils and nutrient-deficient foods, supplementation feels essential — but what if those “healthy” pills are wreaking havoc on your body?A 2022 study in the journal Liver Transplantation reported an increase in liver issues linked to certain herbal and dietary supplements, with cases rising significantly from 1995 to 2020. Additionally, research published in Hepatology highlights that supplements contribute to around 20% of liver-related health concerns nationwide.In this hot health topic episode of Accelerated Health with Sara Banta, I cover the supplements that may be linked to liver health concerns, how to evaluate the quality and safety of supplements, steps to safeguard your liver while maintaining optimal health, and key insights from the latest research on dietary supplements.Supplements Featured In This Episode:• Accelerated Liver Care™ https://www.acceleratedhealthproducts.com/products/accelerated-liver-care • Accelerated Cellular Detox® Powder https://www.acceleratedhealthproducts.com/products/accelerated-cellular-detox-powder • Accelerated Liver Flush Detox Cleanse https://www.acceleratedhealthproducts.com/products/liver-detox-cleanse Not sure what food to eat and avoid? This guide is for you.⬇️

In this episode, hosts Drs. Peter Lu and Jason Silverman talk to Dr. Rima Fawaz about the role of GLP-1 receptor agonists in the treatment of children and adolescents with metabolic dysfunction-associated steatotic liver disease or MASLD (the artist formerly known as non-alcoholic fatty liver disease or NAFLD). We discuss what these medications do, what we know about their positive and negative effects, and how we should be using them based on the current literature. Dr. Fawaz is Medical Director of Pediatric Hepatology and Liver Transplantation at Yale New Haven Children's Hospital and Associate Professor at Yale School of Medicine.Learning Objectives:Understand the therapeutic and potential adverse effects of GLP-1 receptor agonists.Recognize that the foundation of obesity and MASLD treatment remains lifestyle changes focused on diet and exercise.Recognize the role that GLP-1 receptor agonists will play in our care for children and adolescents with obesity and MASLD.Links:Abou Jaoudeh RAR, et al. Pharmacological management of pediatric metabolic dysfunction-associated liver disaese. J Pediatr Gastroenterol Nutr. 2025.Support the showThis episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

This case report describes a 42-year-old male from Arizona with a complex course characterised by fever following an orthotopic liver transplant. A general approach to fever in the post-transplant patient is discussed, along with specific considerations regarding travel in post-transplant patients or those on immunosuppressants for other indications. A/Prof Camille Kotton and Dr Simran Gupta from the Massachusetts General Hospital and Brigham and Women's Hospital take listeners through the case and related issues in a step-by-step manner at a level targeted for trainees and generalists.Guest A/Prof Camille Kotton (Massachusetts General Hospital, Harvard University)Dr Simran Gupta (Brigham and Women's Hospital, Harvard University) HostsAssociate Professor Stephen Bacchi FRACP (Fulbright Fellow, Mass General Brigham; University of Adelaide)Christina Gao (University of Adelaide)ProductionProduced by Stephen Bacchi and Mic Cavazzini. Music licenced from Epidemic Sound includes ‘Rockin' for Decades' by Blue Texas and ‘Brighton Breakdown' by BDBs. Image created and copyrighted by RACP. Editorial feedback kindly provided by doctors Maansi Arora, Brandon Stretton, Matt Lim and Ben Cook.Key Reference (Spoiler Alert)* * * * *Coccidioidal Meningitis after Liver Transplantation in a Nonendemic Region: A Case Report [Transplantation 2006]Please visit the Pomegranate Health web page for a transcript and supporting references.Login to MyCPD to record listening and reading as a prefilled learning activity. Subscribe to new episode email alerts or search for ‘Pomegranate Health' in Apple Podcasts, Spotify,Castbox or any podcasting app.

In the BJANcast season 3 episode 6, Dr. Eduarda Martinelli discuss about "Anesthesia for Liver Transplantation: Challenges and Innovations" with host Dr. André Prato Schmidt. Check out: · Martinelli ES, McCluskey SA, Karkouti K, Luzzi CA, Bieze M, Malbouisson LMS, Schmidt AP. The debate on antifibrinolytics in liver transplantation: always, never, or sometimes? Braz J Anesthesiol. 2024 Nov-Dec;74(6):844562. doi: 10.1016/j.bjane.2024.844562. https://bjan-sba.org/journal/rba/article/doi/10.1016/j.bjane.2024.844562 · Bieze M, Zabida A, Martinelli ES, Caragata R, Wang S, Carroll J, Selzner M, McCluskey SA. Intraoperative hypotension during critical phases of liver transplantation and its impact on acute kidney injury: a retrospective cohort study. Braz J Anesthesiol. 2024 Nov-Dec;74(6):844566. doi: 10.1016/j.bjane.2024.844566. https://bjan-sba.org/journal/rba/article/doi/10.1016/j.bjane.2024.844566 To follow all our networks, visit: https://linktr.ee/bjan #joinBJAN #citeBJAN #webinar #anesthesiology #sba #anestesiologista #anesthesia #transplante #liver

In this episode, hosts Drs. Jason Silverman and Peter Lu sit down with Dr. Vicky Ng to discuss outcomes following pediatric liver transplantation beyond survival. In particular, we review the importance of hearing the patient voice using the PeLTQL, a disease-specific health related quality of life instrument. Dr. Ng is a Professor of Pediatrics at the University of Toronto, Medical Director of the Paediatric Liver Transplantation Transplant and Regenerative Medicine Centre at SickKids Hospital and current President of NASPGHAN. Learning objectives:To understand the benefits of developing a condition-specific health-related quality of life (HRQOL) tool using the Pediatric Liver Transplantation Quality of Life questionnaire (PeLTQL) as a model.To review pre- and post-transplant factors that may impact the HRQOL of pediatric liver transplant recipients.To explore the benefits of the patient (and caregiver) voices in truly understanding important patient outcomes.Links:Development and Validation of the Pediatric Liver Transplantation Quality of Life: A Disease-Specific Quality of Life Measure for Pediatric Liver Transplant RecipientsBarriers to ideal outcomes after pediatric liver transplantationFeasibility of using a patient-reported outcome measure intoclinical practice following pediatric liver transplantation: TheStarzl Network experienceJennifer Vittorio - Healthcare Transitions in Pediatric Liver Transplantation (Special JPGN Episode) - Position paperSupport the showThis episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

Meet a man who had to fly hundreds of miles to donate part of his liver. And learn how and why you can become a living liver donor without making the same journey. Guests include Dr. Ryan Taylor, medical director, Liver Transplantation; Dr. Timothy Schmitt, director of transplantation; Dr. Sean Kumer, transplant surgeon and chief medical officer, Kansas City division; living liver donor Jeff Risinger, living donor recipient Jeff Hull, and his wife, Susan.

Join the experts as they explore the new updates to the liver transplantation clinical practice guidelines, and delve into the latest advancement and ongoing challenges faced in this field.Tune in to:Discover cutting-edge techniques like machine perfusion and extended criteria grafts.Learn about new transplant indications, including oncology and acute liver failure.Understand challenges in immunosuppression and the management of chronic rejection.FacultyAhmed Elsharkawy (Moderator)Didier Samuel (Faculty)Julie Heimbach (Faculty)Sarwa Darwish (Faculty)Related episodesEASL Studio S4E13: JHEP Live: Liver transplantation for alcohol-related hepatitisEASL Studio S4E6: Regenerating the liver graft with a machineEASL Studio S3E2: Liver transplantation for ACLF: Opportunities, challenges, and pitfallsEASL Studio S3E8: Transplanting patients with cancer – Is there a limit?All EASL Studio Podcasts are available on EASL Campus.

Join Prof Simone Strasser as we discuss who, when and how to do early liver transplantation in alcohol associated hepatitis.

Hosts Roz and Josh are joined by Alissar El Chediak, MD to discuss the key articles of the September issue of the American Journal of Transplantation. Alissar El Chediak, MD is a transplant nephrologist at UT Southwestern   [02:55] – Liver Machine Perfusion Technology: Expanding the Donor Pool to Improve Access to Liver Transplantation [08:01] – Editorial: Machine perfusion and liver transplant center behavior: Answers or more questions? [11:01] - Obesity, Organ Failure, and Transplantation: A Review of the Role of Metabolic and Bariatric Surgery in Transplant Candidates and Recipients. [18:48] – Virus Specific T Cell Therapy to Treat Refractory Viral infections in Solid Organ Transplant Recipients [25:08] - Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant [28:48] – Editorial: Virus-specific T-cell efficacy after solid organ transplantation: more questions than answers [34:05] - Successful BK virus–specific T cell therapy in a kidney transplant recipient with progressive multifocal leukoencephalopathy [37:50] - The prevalence of postacute sequelae of coronavirus disease 2019 in solid organ transplant recipients: Evaluation of risk in the National COVID Cohort Collaborative

In the late '80s, a young George Mazariegos, MD, had a one-month rotation with transplant pioneer Thomas E. Starzl, MD. Today, he is chief of Pediatric Transplantation at UPMC Children's Hospital of Pittsburgh and director of Pediatric Transplantation at the Thomas E. Starzl Transplantation Institute. Our hosts cover all things pediatric liver transplantation in Pittsburgh: What conditions require a transplant, what our center has accomplished, growing our transplant network, improving care after transplantation, and more.

Episode 19 - Stacey Beer - Nutrition in Liver Disease and Liver Transplant.In this episode of Nutrition Pearls: the Podcast, co-hosts Melissa Talley and Jen Smith speak with Stacey Beer on nutrition in liver disease and liver transplant.  Stacey Beer is a pediatric dietitian specializing in Gastroenterology, Hepatology, and Nutrition at Texas Children's Hospital, the largest pediatric liver transplant program for the past 15 years. Stacey has presented posters at national conferences related to pediatric transplant. Stacey serves as a member of the NATCO Nutrition Board and was instrumental in the creation of the Certified Clinical Transplant Dietitian certification. In 2022, Stacey was awarded the inaugural NASPAGHAN CPNP Dietitian of Excellence Award and in 2023 she was awarded the Jeanette Hasse Transplant Dietitian of the Year award. Most recently, Stacey has created a transplant education program in transplant nutrition which is available for dietitians all over the world to learn more about transplant nutrition. Stacey's research interests are pediatric transplant, pediatric liver disease and parenteral nutrition. Nutrition Pearls is supported by an educational grant from Reckitt Mead Johnson Nutrition.Resources:Beer SS, Vega MW. Malnutrition, sarcopenia, and frailty assessment in pediatric transplantation. Nutr. Clin. Pract. 2023;1–18. DOI: 10.1002/ncp.11105.Boster JM et al. Malnutrition in Biliary Atresia: Assessment, Management, and Outcomes. Liver Transplantation. 2022(28)483‒492.Kamath BM et al. Fat Soluble Vitamin Assessment and Supplementation in Cholestasis. Clin Liver Dis. 2022(26)537–553.Degrassi I et al. Fat-Soluble Vitamins Deficiency in Pediatric Cholestasis: A Scoping Review. Nutrients. 2023(15)2491. https://doi.org/10.3390/nu15112491.Health Well: https://www.healthwellfoundation.org/fund/alagille-syndrome-vitamins-and-supplements/FDA Post Transplant: https://www.fsis.usda.gov/sites/default/files/media_file/2021-04/at-risk-booklet.pdfPracticum Link (applications for the fall program are due July 3, 2024): https://www.texaschildrens.org/health-professionals/education-and-training/conferences/pediatric-transplant-nutrition-practicumProduced by: Corey IrwinNASPGHAN - Council for Pediatric Nutrition Professionalscpnp@naspghan.org

Welcome to our four-episode series: Raising Awareness of Hepatorenal Syndrome Acute Kidney Injury (HRS-AKI). In our final episode, our host Muhamad Nadeem Yousaf, MD, speaks with Vivian Ortiz, MD, and Neil Shah, MD, to delve into critical aspects of HRS-AKI. They cover the prognosis after initial management, the significance of reversing renal impairment for liver transplant candidates, the predictive role of MELD score in HRS-AKI, treatment's impact on liver transplant waiting lists, decision-making between liver transplant alone or simultaneous liver-kidney transplant, timing considerations for kidney transplant post-liver transplant, and factors affecting post-transplant prognosis. Each episode of this series corresponds to a journal article from a September 2023 supplement of Clinical Gastroenterology and Hepatology (CGH), the official clinical practice journal of the American Gastroenterological Association, focusing on addressing knowledge gaps in HRS-AKI. To read the related journal articles and claim CME for listening, visit agau.gastro.org. This series is supported by an independent educational grant from Mallinckrodt

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Michael Lucey, MD There are a lot of considerations to keep in mind when it comes to liver transplantation in patients with various diseases, like metabolic-associated stereotactic liver diseases, alcoholic liver disease, hepatitis B and C, and more. Joining Dr. Peter Buch to discuss those key considerations surrounding liver transplantation is Dr. Michael Lucey, Professor of Medicine at the University of Wisconsin School of Medicine and Public Health.

Welcome to the next installment of the Anesthesia Patient Safety podcast hosted by Alli Bechtel.  This podcast is an exciting journey towards improved anesthesia patient safety.We have talked about anesthesia patient safety in different areas of the hospital from the maternity wards to non-operating room anesthesia suites, but this time, we are heading into the main operating room to talk about one of the most challenging cases in the operating rooms with frequent hemodynamic changes, the possibility for massive blood loss and coagulopathy in sick patients and often that takes place in the middle of the night. That's right, we are talking about keep patients safe during liver transplantation and returning to episodes #147 and #148 for a massive, revisited episode.Additional sound effects from: Zapsplat.For show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/187-keeping-patients-safe-during-liver-transplantation-revisited/© 2024, The Anesthesia Patient Safety Foundation

For our second episode, DPhil student Frances Hand talks to Dr Julia Rehsmann about the important role that waiting plays in liver transplantation procedures. We consider how waiting can provide not only a community, but an opportunity for valuable reflection in times of uncertainty.

Join John, Paul and Will for this enlightening discussion demystifying liver transplantation. The discussion spans the past, present and future of liver transplantation. All the way from early days of transplantation through to the concepts of xenotransplantation.

In another special JPGN episode, hosts Drs. Jennifer Lee and Jason Silverman talk to Dr. Jennifer Vittorio about the important topic of healthcare transition for adolescents following liver transplantation, which is covered in the recent NASPGHAN position paper: Health Care Transition for Adolescents and Young Adults With Pediatric-Onset Liver Disease and Transplantation: A Position Paper by the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition. This episode is eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!Links for this episode:Transition post-transplant position paperGot TransitionLearning Objectives:Understand the important differences between healthcare transition and transfer of careDiscuss the six core components of healthcare transitionReview the dimensions of transition readiness and tools for their assessmentProduced by: Jason SilvermanSupport the showAs always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Follow us on Twitter, Facebook and Instagram for all the latest news and upcoming episodes!

Dr. Arvinder Singh Soin is the Chief Hepatobiliary and Liver Transplant Surgeon & Chairman of the Institute of Liver Transplantation and Regenerative Medicine, Medanta - The Medicity, Gurugram. A surgeon and pioneer in the field of liver transplantation, acknowledged for his work in establishing liver transplantation in India. Dr. Soin also runs the Liver Transplant institute at the Sir H. N. Reliance Foundation Hospital, Mumbai. Dr Soin has performed more than 4,000 liver transplants in India which is the highest in the country, and the second-highest in the world.

Rick Greene, MD, discusses with Dr. Giammauro Berardi, MD, PhD, FEBS, the outcomes of a large cohort of patients undergoing upfront surgery for resectable colorectal liver metastases (CRLM) to analyze the predictability and probability of early treatment failure using clinicopathological characteristics. Dr. Berardi is author of, “A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases.” Dr. Berardi is attending at the Department of HPB Surgery and Liver Transplantation of the San Camillo Forlanini Hospital, Rome, Italy, and previous to that was a Surgical Oncology clinical fellow at Memorial Sloan-Kettering Cancer Center, New York NY.

Jasmohan Bajaj (Virginia Commonwealth University and Central Virginia Veterans Healthcare System, Richmond, VA, USA), on behalf of the CLEARED Consortium, discusses a prospective observational cohort study examining global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis.Read the full article:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00098-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langasContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Alan Bonder, MD According to this clinician, the most important thing for primary biliary cholangitis (PBC) patients is the diagnosis, and anyone with abnormal liver tests should be sent an antimitochondrial antibody (AMA). Dive into this interview with host Dr. Peter Buch and Dr. Alan Bonder, Assistant Professor of Medicine and the Medical Director of Liver Transplantation at Beth Israel Medical Center in Boston.

Commentary by Dr. Valentin Fuster

Commentary by Dr. Valentin Fuster

In this final episode in our liver surgery series, host Rick Greene, MD, FACS, continues to discuss liver malignances and transplantation with Zachary C. Dietch, MD, member of the abdominal transplant team at Northwestern University Hospital in Chicago, IL. Learn more about Selected Readings in General Surgery, an American College of Surgeons publication that highlights highly relevant and practice-changing information from the world's most prominent medical journals. #SurgicalReadings #SRGS

Welcome to the next installment of the Anesthesia Patient Safety podcast hosted by Alli Bechtel.  This podcast is an exciting journey towards improved anesthesia patient safety.We have talked about anesthesia patient safety in different areas of the hospital from the maternity wards to non-operating room anesthesia suites, but this time, we are heading into the main operating room to talk about one of the most challenging cases in the operating rooms with frequent hemodynamic changes, the possibility for massive blood loss and coagulopathy in sick patients and often that takes place in the middle of the night. That's right, we are talking about keep patients safe during liver transplantation.Additional sound effects from: Zapsplat.© 2023, The Anesthesia Patient Safety FoundationFor show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/147-keeping-patients-safe-during-liver-transplantation/

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Alan Bonder, MD Patients with underlying autoimmune diseases could be at a higher risk of developing autoimmune hepatitis (AIH). So what challenges might occur when diagnosing patients with AIH? Learn more with Dr. Peter Buch as he discusses this with Dr. Alan Bonder, Director of Liver Transplantation at Beth Israel Deaconess Hospital and an Assistant Professor of Medicine at Harvard Medical School.

The topic of liver transplantation for alcohol-related hepatitis is controversial. While some experts still recommend 6 months of alcohol abstinence before considering transplantation others advocate for early transplantation.Watch this episode to:Understand the epidemiology of alcohol-related hepatitis.Know which treatment options are available to these patientsFind out which patients may benefit from earl liver transplantation.FacultyProf. Patrizia Burra (Moderator)Dr Giacomo Germani (Faculty)Prof. Alexandre Louvet (Faculty)Related episodesS4E6 – Regenerating the liver graft with a machineS3E5 – JHEP Live: Stigma and alcoholAll EASL Studio Podcasts are available on EASL Campus.

Our liver is something we often don't think much about - until there's a problem. When faced with liver disease, whether from alcohol, obesity, hepatitis or even genetic, transplantation might be necessary. Dr. Narayanan Menon, Medical Director of Medical City Liver and Digestive Disease Specialists & Medical Director of Liver Transplantation at Medical City Dallas Transplant Institute joins us for a comprehensive discussion about liver disease, including prevention. There is a fairly new technology that became invaluable during the pandemic that is a tremendous life-saving technology. It is called ECMO and replaces both the heart and lung functions until the body can heal. Dr. Ramesh Subedi, Pulmonologist at Texas Health Harris Methodist Hospital Fort Worth tells us all about it.

In this episode, Maria Buti, MD, and Richard H. Davis, PA-C, address key considerations when screening, diagnosing, and treating patients with hepatitis delta virus (HDV), such as:Barriers to screening HDV screening based on patient risk factors Universal screening for all patients with positive hepatitis B surface antigen (HBsAg)Reflex testing Availability of commercial testingMonitoring suggestions in HBsAg positive and HDV antibody positive patients with negative HDV RNALimitations to evaluating advanced fibrosis in patients with HDVData on novel HDV therapies (eg, bulevirtide and lonafarnib)Extending HDV therapy (eg, peginterferon) based on treatment responseStopping rules (eg, HDV RNA negativity, HBsAg loss) for discontinuing HDV therapyFaculty:Maria Buti, MDProfessor of MedicineHospital Universitario Vall d'HebronBarcelona, SpainRichard H. Davis, PA-CSenior PAGastroenterologyUniversity of FloridaUF HealthGainesville, FloridaLink to full program: http://bit.ly/3yp1Lxf

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Koji Hashimoto, MD, PhD What facts should we keep in mind when considering liver transplantation? And how do we determine which of our patients are the right candidates? Dr. Peter Buch explores important considerations for liver transplantation with Dr. Koji Hashimoto, the Director of Liver Transplantation at the Cleveland Clinic.

In this video, Dr. Matthew Kappus, MD, Medical Director of Living Donation, Liver Transplantation and Assistant Professor of Medicine, Gastroenterology and Transplant Hepatology at Duke University School of Medicine shares how his search to fill a void in treating the frailty of liver patients lead him to nutrition. It was a journey he had to figure out on his own, since there is no formalized pathway to nutrition. He uses the liver frailty index to compare and contrast the effectiveness of interventions, whether its nutrition intervention or physical therapy intervention. Dr. Kappas stresses that nutrition should not be an afterthought for it is not understood by all, and often overlooked. Nutrition affects every practice and it's important for young physicians to have an open mind and find creative ways to incorporate nutrition into their practice. Physician Spotlight is a forum for outstanding Senior Leaders, Young Rising Stars, and International Colleagues in the field of nutrition to discuss important topics and ideas that impact patient care. Visit the ASPEN Physician Community at www.nutritioncare.org/physicians December 2022

Join Dr. Vijay Subramanian to identify treatment of liver cancers, discuss indications for transplant, and explore the journey to liver transplant and post-transplant outcomes. AccreditationsPHYSICIANSACCMEUSF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. USF Health designates this live activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Florida Board of MedicineUSF Health is an approved provider of continuing education for physicians through the Florida Board of Medicine. This activity has been reviewed and approved for up to 0.25 continuing education credits. Target Audience: Gastroenterologists, Hepatologists, OncologistsRelease Date: 12/20/2022Expiration Date: 12/20/2023 Relevant Financial RelationshipsAll individuals in a position to influence content for this activity have disclosed to USF Health any financial relationship they have with an ineligible organization. There are no relevant financial relationship to disclose or mitigate.Claim CME/CEU Credit for this episode here: https://cmetracker.net/USF/Publisher?page=pubOpen#/getCertificate/355287

In this episode, Nancy Reau, MD, and Coleman I. Smith, MD, discuss the burden of undiagnosed hepatitis delta virus (HDV) infection and who should be tested, including:Epidemiology of HDV infectionClinical course of HDV infectionPopulations at high risk of HDV infectionGuidelines for HDV testingFaculty: Nancy Reau, MDProfessor of MedicineChief, Section of Hepatology Associate Director, Solid Organ Transplantation Richard B. Capps Chair of HepatologyRush University Medical CenterChicago, IllinoisColeman I. Smith, MDProfessor of MedicineHepatologistGeorgetown Transplant InstituteGeorgetown UniversityWashington, DCLink to full program: https://bit.ly/3WmJnziFollow along with the slides at:https://bit.ly/3NpAYI1

In this CLASSIC Aging Matters episode, host Cheryl Beversdorf talks with Rohit Satoskar, MD, Director, Medical Services, MedStar Georgetown Transplant Institute, and Medical Director, Liver Transplantation, about liver diseases and liver transplant process.

This EASL Studio discusses important issues related to the opportunities and challenges of liver transplantation in acute-on-chronic liver failure (ACLF).Does urgent liver transplantation improve the survival of patients with ACLF-3 and where are the limits?Are the current allocation systems adequate and how to implement ACLF criteria for prioritisation?The distinct lack of equity of access of ACLF-3 patients to liver transplantation: Where are the barriers?What data will the CHANCE study deliver to address some of the unanswered questions?All EASL Studio Podcasts are available on EASL Campus.

Audible Article by Claire R. Harrington and Josh Levitsky

Commentary by Dr. Mary Norine Walsh and Dr. Masataka Kawana

Audible Article by Oren K. Fix and Vandana Khungar

Dr. Bill Wall is one of the pioneers of liver transplantation, especially in Canada. We spoke to him on this episode about his training, the early days of transplantation and about his new children's book! Links: 1. Member of the Order of Canada: https://www.gg.ca/en/honours/recipients/146-9121 Bio (from https://www.gg.ca/en/honours/recipients/146-9121) William Wall is a dedicated and compassionate physician whose surgical and clinical proficiency have benefited many Canadians with end-stage organ disease. Professor of surgery at the University of Western Ontario, he established Canada's first liver transplant program at the London Health Sciences Centre, where he is director of the Multi-Organ Transplant Program. In this role, he has promoted excellence in research and patient care, as well as public awareness and support for organ donation. Widely respected by his peers, he served as president of the International Liver Transplantation Society.

Cristiano Quintini, MD, is the Program Director and Surgical Director of Cleveland Clinic's Liver Transplantation Program. In this episode of Butts and Guts, Dr. Quintini provides insight into what information is considered prior to a liver transplant and also discusses several strategies that be implemented when performing this type of surgery.

In this collaborative episode with JPGN, Drs. Peter Lu and Jason Silverman talk to Dr. Jim Squires, the first author of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on the Diagnosis and Management of Pediatric Acute Liver Failure published recently in JPGN. Although this is a complex syndrome and topic, the discussion highlights important principles to consider and an initial approach to patients with this condition. Dr. Squires is Associate Director of Hepatology and Fellowship Director for Pediatric Transplant Hepatology at the University of Pittsburgh.Want to learn more about Pediatric Acute Liver Failure (PALF)? Join us on April 14 at 7 pm EST for the FIRST #PedsGIChat! Follow the hashtag and @PedsGIChat for a great discussion with Dr. Mohit Kehar on this topic, and keep following for news about future chats as well! Our thanks to the NASPGHAN Technology Committee for setting this up!This episode is eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!Learning Objectives:Understand the initial assessment and triage of a patient with suspected PALF.Understand the diagnostic evaluation of infants and children with PALF.Review the ongoing monitoring of patients with PALF to assess for complications.Links:NASPGHAN Position Paper on the Diagnosis and Management of Pediatric Acute Liver FailureFollow the conversation on Twitter!JPGN Fellow Reviewer Program application formAs always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Support the show (https://www.naspghan.org/content/87/en/foundation/donate)

Jennifer Cohen interviews Nicole Wells, MA, Program Manager, Pediatric and Rare Liver Diseases at Global Liver Institute, who discusses her experiences with liver transplantation, her advocacy, and her interest in healthcare policy. Nicole is a native of Kentucky and taught school in the US Virgin Islands. As a transplant recipient herself, Nicole provides valuable insights on the process of diagnosis and realizing the need for transplant, and then walks our listeners through the process of how the donor list works and how she found her liver donor.

How do you discuss a disease with no history during Black History month? Surfing the NASH Tsunami asked, "What challenges exist for non-Hispanic Black Americans in the areas of NAFLD and NASH, given how low incidence is?" In this conversation, a corporate executive, not-for-profit patient champion and academic researcher discuss some of the reasons it is so important to identify and address these issues today.Yani Adere, NASH MSL at Novo Nordisk and the person who pitched the episode idea to Roger Green, kicks off this conversation by discussing issues that concern and motivate her, She notes that even with lower incidence than other racial groups, NASH is still the second leading cause of liver transplant in non-Hispanic blacks and that the course of the disease is similar in black and Caucasians. Next, Global Liver Institute Founder and CEO Donna Cryer notes that since NASH is a disease without much history, we can make Black History in realtime by introducing clinical trial protocols, treatment modalities and population screening programs that address specific challenges facing that community. Next, Dr. Zaki Sherif of Howard University notes that end-stage liver disease in non-Hispanic Black communities has two challenges: faster progression from cirrhosis to HCC than other groups and lower likelihood to receive a liver transplant. During the rest of this conversation, Dr. Ani Kardashian of the Keck School of Medicine at USC, Zaki and Donna comment on several addressable issues that explain why liver outcomes are lower for non-Hispanic Blacks than for other racial groups.

Liver Transplantation for the Treatment of Liver Cancer with guest Dr. Ariel Jaffe November 28, 2021 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Liver Transplantation for the Treatment of Liver Cancer with guest Dr. Ariel Jaffe November 28, 2021 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Conversation with Rohit Satoskar, MD, Director, Medical Services, MedStar Georgetown Transplant Institute, and Medical Director, Liver Transplantation, about liver diseases - risk factors, signs/symptoms, diagnosis/treatment, and liver transplant process

Adam and Alex have a chat about life changes (0:04-3:00) before welcoming in Dr. Elliot Tapper for a far-reaching conversation, touching upon mentorship and "menteering", how to say NO as a trainee and, naturally, Bravo reality TV (3:04-36:19). Then, Adam teases a new and welcome change to the transplant hepatology fellowship application process. Finally, Alex discusses his new publication in Liver Transplantation studying the impact of early liver transplant for alcoholic hepatitis on cost and healthcare utilization (36:30-47:00). Dr. Tapper's "menteering" paper: https://www.gastrojournal.org/article/S0016-5085(17)30228-7/fulltext Alex's paper on the healthcare utilization and costs for transplantation in ALD: https://pubmed.ncbi.nlm.nih.gov/34133847/ Feedback? Want to suggest a topic or a guest? E-mail us @ liverfellownetwork@gmail.com or tweet tweet us @LiverFellow. Hosts: Adam Winters @adam_c_winters Alex Vogel @AlexSVogel Guest: Elliot Tapper @ebtapper Music Credits: “Tropkicks”, Broke for Free “Something Elated”, Broke for Free “Take Me Higher”, Jahzzar “RSPN,” Blank & Kytt All music furnished by https://freemusicarchive.org/ under Creative Commons licensing. http://brokeforfree.com/ https://jahzzar.bandcamp.com/ https://blankkytt.bandcamp.com/

In this episode, we explore disparities within the field of liver transplantation with Dr. Lauren Nephew, an Assistant Professor of Medicine and researcher at the Indiana University School of Medicine. Dr. Nephew talks with Alex about disparities throughout the spectrum of care as well as potential solutions. Link to Dr. Nephew's paper in Liver Transplantation: https://aasldpubs.onlinelibrary.wiley.com/doi/10.1002/lt.25996 Hosts: Adam Winters: @adam_c_winters Alex Vogel: @AlexSVogel Guest: Lauren Nephew MD MAE MSc: @LaurenNephewMD Music Credits “Tropkicks”, Broke for Free “Something Elated”, Broke for Free “Take Me Higher”, Jahzzar “RSPN,” Blank & Kytt All music furnished by https://freemusicarchive.org/ under Creative Commons licensing. http://brokeforfree.com/ https://jahzzar.bandcamp.com/ https://blankkytt.bandcamp.com/

FDA 批准鱼油脂肪乳用于肠道衰竭相关肝病儿童的治疗JAMA 持续肺膨胀与间歇正压通气对极早产儿支气管肺发育不良NEJM 喉罩通气在新生儿复苏中的随机试验European Respiratory Journal 利用早产儿心率特征指数预测拔管结果Scientific Report 肠道菌群移植治疗对自闭症ω-3鱼油脂肪乳（fish oil triglycerides）2018年7月，FDA批准ω-3鱼油脂肪乳（fish oil triglycerides）作为儿童肠外营养相关胆汁淤积症患者的热量和脂肪酸来源。《多阶段回顾性分析：作为热量和脂肪酸的来源，静脉注射鱼油脂肪乳可促进患有肠道衰竭相关肝病的患儿的适龄生长》Journal of Pediatrics，2020年4月 (1)研究的目的是比较静脉注射鱼油脂肪乳（fish oil liquid emulsion，FOLE）和静脉注射大豆油脂肪乳（soybean oil liquid emulsion，SOLE）治疗肠衰竭相关性肝病（intestine failure associated liver disease，IFALD）患儿的疗效和患儿的生长情况。研究纳入41名患儿和82例历史对照组，接受开放标签鱼油脂肪乳 (1g/kg/d），直到IFALD消失或停止肠外营养；历史对照组接受大豆油脂肪乳（3g/kg/d）的治疗。 28周后，接受鱼油脂肪乳治疗的患儿的平均体重的z评分在-1到1范围内，显示出与年龄相适应的生长。与大豆油脂肪乳治疗的患儿相比，鱼油脂肪乳治疗的患儿的前白蛋白更高、甘油三酯更低、血糖浓度更正常。结论：与接受大豆油脂肪乳的儿童相比，接受鱼油脂肪乳的IFALD儿童生长指标更正常、代谢异常更少。《多中心回顾性分析鱼油脂肪乳减少肠衰竭相关肝病患儿肝损伤及肝移植风险》Journal of Pediatrics，2020年10月 (2)研究旨在比较经静脉注射鱼油脂肪乳（FOLE）和大豆油脂乳（SOLE）治疗的肠衰竭相关肝病患儿的转氨酶与血小板比值指数、肝移植和死亡率。在这项多中心综合分析中，将189例接受鱼油脂肪乳（1g/kg/d）治疗的儿童，与73例接受大豆油脂肪乳（3g/kg/d）的历史对照组进行比较。与历史对照组相比，接受鱼油脂肪乳的患儿在基线时的直接胆红素水平更高（212.28μmol/L vs 109.8μmol/L，P

Professor Peter Friend, Dr David Nasralla and Dr Carlo Ceresa discuss liver transplantation and why they are replacing conventional cold storage in an ice box with normothermic automated, transportable liver preservation. Professor Peter Friend is Professor of Transplantation at the Nuffield Department of Surgical Sciences, and Dr David Nasralla and Dr Carlo Ceresa are Clinical Research Fellows in Transplant Surgery at NDS, University of Oxford. This research has been published in the journal Nature. Please visit: https://www.nature.com/articles/s41586-018-0047-9